Catriona Yale Akero Therapeutics, Inc. (AKRO) insider trading activity
Catriona Yale is Chief Development Officer of Akero Therapeutics, Inc.. Currently has a direct ownership of 75,931 shares of AKRO, which is worth approximately $2 Million. The most recent transaction as insider was on Dec 09, 2022, when has been sold 19,195 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
75.9K
2.27%
3M change
62.85%
12M change
Total Value Held
$2 Million
Catriona Yale Transaction History
CY
Catriona Yale
Chief Development Officer
South San Francisco, CA